ASTRAZENECA PLC (AZN)
Clinical trial NCT07082738: enrollment: 1160 → 987 participants.
Clinical trial NCT07082738: enrollment: 1160 → 987 participants.
Clinical trial NCT05419479 updates: 1. completion date: 2028-09-30 → 2032-05-17 2. primary completion date: 2027-01-31 → 2026-05-17
Clinical trial NCT07617961: completion date: 2026-05-21 → 2027-05-21.
Clinical trial NCT05992480 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-05-01 → 2026-11-01 3. primary completion date: 2026-05-01 → 2026-11-01 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05575492 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-01-15 → 2026-05-12 3. primary completion date: 2027-01-15 → 2026-05-12
Clinical trial NCT05959083 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-05-07 3. primary completion date: 2026-06-01 → 2026-05-07
Clinical trial NCT07583563 updates: 1. start date: 2026-05-01 → 2026-06-01 2. completion date: 2029-05-01 → 2029-06-01 3. primary completion date: 2029-05-01 → 2029-06-01
Clinical trial NCT06548555: enrollment: 120 → 121 participants.
Clinical trial NCT07562152: start date: 2026-05-01 → 2026-06-01.
NetApp与Cisco携手强化企业级网络韧性的纵深防御体系